BBLG 股價走勢圖
BBLG 股票價格預測
Bone Biologics Corp
$1.46
-0.68%
$-0.01
收盤價：Jun 18, 16:00:00 GMT-4
$1.39
-4.77%
$-0.06
盤前：Jun 22, 05:49:20 GMT-4
返回
Bone Biologics Corp (BBLG) 股票價格預測
關鍵數據
前收市價
$1.47
開盤價
$1.53
當日範圍
$1.37 - $1.53
52週區間
$1.05 - $6.75
交易量
469.0K
平均成交量
17.3K
股息收益率
--
每股盈餘 (TTM)
-2.51
市值
$2.5M
什麼是 BBLG？
Bone Biologics Corp. operates as a medical device company. The company is headquartered in Burlington, Massachusetts and currently employs 2 full-time employees. The company went IPO on 2015-11-27. The firm is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
